Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

AXTA PEER ANALYSIS

Axalta Coating Systems Ltd — metric-by-metric comparison with peers and the industry median

AXTAAxalta Coating Systems Ltd

🇺🇸 USA · NYSE · Basic Materials · Specialty Chemicals

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Specialty Chemicals

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
AXTAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
AXTA+13.4%ORI+23.3%BNR+4.7%IMCD-25.3%DNL+43.2%AKZA+3.6%
Year-to-Date (YTD)
AXTA+6.0%ORI-1.2%BNR+16.6%IMCD+9.0%DNL+20.1%AKZA+4.2%
1-Year
Split-adjusted
AXTA+13.4%NEU+9.6%EMN-6.6%WLK-0.5%PRM+118.7%BCPC+4.1%
Year-to-Date (YTD)
AXTA+6.0%NEU+16.8%EMN+11.6%WLK+4.3%PRM+21.5%BCPC+9.6%

Key Metric Comparison

P/E

Lower is better
AXTA19.92ORI44.06BNR35.37IMCD22.50DNL—AKZA16.51Median 27.59

ROE

Higher is better
AXTA16.4%ORI6.1%BNR5.0%IMCD10.2%DNL3.8%AKZA13.1%Median 4.4%

Net Margin

Higher is better
AXTA7.2%ORI3.1%BNR1.5%IMCD4.5%DNL4.5%AKZA6.3%Median 3.5%

Revenue Growth

Higher is better
AXTA-2.6%ORI1.8%BNR-9.5%IMCD1.2%DNL-16.6%AKZA-7.0%Median 1.2%

P/E

Lower is better
AXTA19.92NEU18.25EMN20.05WLK—PRM—BCPC34.33Median 27.59

ROE

Higher is better
AXTA16.4%NEU25.3%EMN6.7%WLK-17.3%PRM-15.7%BCPC12.7%Median 4.4%

Net Margin

Higher is better
AXTA7.2%NEU15.3%EMN4.6%WLK-14.9%PRM-26.9%BCPC15.0%Median 3.5%

Revenue Growth

Higher is better
AXTA-2.6%NEU-3.5%EMN-7.7%WLK-8.6%PRM23.0%BCPC9.6%Median 1.2%

All Metrics

Valuation
MetricAXTAORIBNRIMCDDNLAKZAInd. Median
P/E19.9244.0635.3722.50—16.51●27.59
P/B3.042.961.802.401.70●2.101.79
EV/EBITDA9.849.689.2512.2112.468.38●12.38
P/S1.441.370.55●1.021.841.031.67
Financial Health
MetricAXTAORIBNRIMCDDNLAKZAInd. Median
Current Ratio2.10●1.311.741.731.271.721.87
Debt/Equity130.0%86.9%75.4%83.4%39.7%●125.2%63.0%
NetDebt/EBITDA2.531.77●2.312.812.151.942.15
Profitability
MetricAXTAORIBNRIMCDDNLAKZAInd. Median
Net Margin7.2%●3.1%1.5%4.5%4.5%6.3%3.5%
ROE16.4%●6.1%5.0%10.2%3.8%13.1%4.4%
ROA4.9%●2.5%2.0%4.6%2.2%4.1%2.0%
EBITDA Margin19.7%●17.3%7.9%10.9%17.8%16.0%14.7%
Growth + Dividend
MetricAXTAORIBNRIMCDDNLAKZAInd. Median
Rev. Growth-2.6%1.8%●-9.5%1.2%-16.6%-7.0%1.2%
NI Growth-17.8%155.6%●-56.9%-21.8%—32.7%-4.8%
Div. Yield0.0%2.5%3.4%2.2%3.6%●3.3%1.5%
Payout0.0%107.9%132.9%58.4%126.7%56.0%9.1%
Valuation
MetricAXTANEUEMNWLKPRMBCPCInd. Median
P/E19.9218.25●20.05——34.3327.59
P/B3.044.321.331.14●4.584.221.79
EV/EBITDA9.84●11.8510.71——20.4712.38
P/S1.442.780.930.89●7.825.131.67
Financial Health
MetricAXTANEUEMNWLKPRMBCPCInd. Median
Current Ratio2.102.551.472.173.09●2.551.87
Debt/Equity130.0%58.9%88.6%75.1%113.4%14.4%●63.0%
NetDebt/EBITDA2.531.333.94-8.78-9.65●0.412.15
Profitability
MetricAXTANEUEMNWLKPRMBCPCInd. Median
Net Margin7.2%15.3%●4.6%-14.9%-26.9%15.0%3.5%
ROE16.4%25.3%●6.7%-17.3%-15.7%12.7%4.4%
ROA4.9%12.2%●2.6%-8.1%-6.8%9.5%2.0%
EBITDA Margin19.7%26.4%●13.7%-4.1%-18.7%25.6%14.7%
Growth + Dividend
MetricAXTANEUEMNWLKPRMBCPCInd. Median
Rev. Growth-2.6%-3.5%-7.7%-8.6%23.0%●9.6%1.2%
NI Growth-17.8%-14.5%-56.7%——15.8%●-4.8%
Div. Yield0.0%1.5%5.0%●2.9%—0.6%1.5%
Payout0.0%26.2%95.5%-16.6%—19.5%9.1%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AXTA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.